News
Matinas BioPharma Holdings, Inc.'s Revenue of 0 K ranks in the 0.0% percentile for the Sector. The following table provides additional summary stats: ...
Matinas BioPharma Holdings, Inc. - GlobeNewswire - Fri Jan 10, 4:15PM CST BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE ...
BEDMINSTER, NJ - Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American: MTNB), a Delaware-incorporated pharmaceutical company, disclosed in a recent SEC filing that Kathryn Penkus Corzo has ...
BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma (MTNB) Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet ...
BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet ...
Matinas BioPharma (NYSE:MTNB) Holdings, Inc., a pharmaceutical company, announced a trading halt of its common stock on the NYSE American due to a low trading price. This halt is anticipated to ...
BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies ...
BEDMINSTER, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies ...
Matinas BioPharma Holdings, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome, everyone, to the Matinas ...
BEDMINSTER, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback